Form 8-K - Current report:
SEC Accession No. 0001193125-24-237160
Filing Date
2024-10-15
Accepted
2024-10-15 06:14:30
Documents
17
Period of Report
2024-10-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d857185d8k.htm   iXBRL 8-K 54923
2 EX-2.1 d857185dex21.htm EX-2.1 545779
3 EX-99.1 d857185dex991.htm EX-99.1 45369
7 GRAPHIC g857185g1015030252679.jpg GRAPHIC 2117
8 GRAPHIC g857185g84f03.jpg GRAPHIC 41452
  Complete submission text file 0001193125-24-237160.txt   990851

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA lbph-20241014.xsd EX-101.SCH 2875
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE lbph-20241014_lab.xml EX-101.LAB 18738
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lbph-20241014_pre.xml EX-101.PRE 11724
19 EXTRACTED XBRL INSTANCE DOCUMENT d857185d8k_htm.xml XML 3777
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

EIN.: 845009619 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40192 | Film No.: 241369066
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)